Arkolith/Insider Trading/MDGL/Form 4

Taub Rebecca

DirectorMADRIGAL PHARMACEUTICALS, INC. (MDGL) · full profile →Form 4 · filed Jan 13, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$132K
Net Open-Market Flow
-$132K
Transactions
4
3 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 9, 2026Sell(S)200$551.24$110K456K
Jan 9, 2026Option exercise(M)240$15.80$4K456K
Jan 9, 2026Sell(S)40$545.79$22K456K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 9, 2026Option exercise(M)240—$00

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001628280-26-001970) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML